# Beam Therapeutics Inc. (BEAM) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$384M |
| 2024 | -$416M |
| 2023 | -$176M |
| 2022 | -$338M |
| 2021 | -$392M |
| 2020 | -$133M |
| 2019 | -$75M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$107M |
| 2025-09-30 | -$127M |
| 2025-06-30 | -$120M |
| 2025-03-31 | -$119M |
| 2024-09-30 | -$107M |
| 2024-06-30 | -$105M |
| 2024-03-31 | -$104M |
| 2023-09-30 | -$108M |
| 2023-06-30 | -$102M |
| 2023-03-31 | -$99M |
| 2022-09-30 | -$91M |
| 2022-06-30 | -$82M |
| 2022-03-31 | -$76M |
| 2021-09-30 | -$70M |
| 2021-06-30 | -$59M |
| 2021-03-31 | -$200M |
| 2020-09-30 | -$37M |
| 2020-06-30 | -$26M |
| 2020-03-31 | -$28M |
| 2019-09-30 | -$18M |
| 2019-06-30 | -$18M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BEAM/operating-income)